首页 >> 师资力量 >> 师资队伍 >> Z >> 正文

师资力量

周博达

临床教研系列准聘副教授

副主任医师

学科方向:心脏病学

zhouboda@tsinghua.edu.cn

教育背景

2013年毕业于北京大学,获得临床医学博士学位(本博连读)。在读期间,入选北京大学医学部医师-科学家培养计划,公派赴英国King’s College London(诺奖获得者James Black Centre)进行基础研究联合培养。2019年及2020年在Harvard Medical School分别获得Faculty Development Program、Global Clinical Scholars Research Training Program课程认证,2019年于国家卫健委受心血管介入培训。

工作履历

2022.07至今 清华大学 准聘副教授(临床教研系列,Tenure Track)

2020.12至今 北京清华长庚医院 心内科副主任医师

2018.08-2020.12 北京清华长庚医院 心内科主治医师

2016.08-2018.08 北京大学第三医院心血管内科主治医师

2013.08-2016.08 北京大学第三医院心血管内科住院医师及住院总医师

研究方向

临床专业方向为精准冠心病介入治疗与肿瘤心脏病学,主要研究方向是心血管代谢疾病的人工智能诊断和创新药物研发。

学术论著(部分) (*通讯作者,#第一作者)

1. Fan H, Zhou B*. Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine. 2026 Apr 7; https://doi.org/10.1056/NEJMc2602975(*corresponding author,IF=84.5)

2. Shargie MB, Zhou B*, Yu H. Ebola preparedness must start with ecosystems and before humans show symptoms. Nature. 2026 Jul;655(8121):274. doi: 10.1038/d41586-026-02070-x. (*corresponding author,IF=56.1)

3. Fan H, Zhou B*. Aspirin's Echo: Rebound, Delay, or Statistical Mirage? Re-examining Legacy Cardiovascular Risk After Cessation. European Heart Journal. Volume 47, Issue 2, 7 January 2026, Page 273.(*corresponding author,IF=45.3)

4. Yan S, Zhou B*. Circulating FGF21 levels reflect liver disease risk and metabolic stress in the UK Biobank, Journal of Hepatology, 2026 Apr 29:S0168-8278(26)00223-0. doi: 10.1016/j.jhep.2026.04.020.(*corresponding author,IF=40.1)

5. Weicheng Lai, Shenshen Du, Liangxiu Wu, Boda Zhou*. Systemic assessment via Cardiovascular-Kidney-Metabolic (CKM) staging complements the longitudinal evaluation of liver stiffness in MASLD. Journal of Hepatology. 2026 Mar 13, https://doi.org/10.1016/j.jhep.2026.03.011.(*corresponding author,IF=40.1)

6. Maxwell Ahiafor, Wang Zhong, Boda Zhou* (2026) Acknowledgment Is Not Enforcement: Closing Commercial AI Recruitment’s Transparency Gap, The American Journal of Bioethics, 26:8, 67-69, DOI: 10.1080/15265161.2026.2690948.(*corresponding author,IF=17.6)

7. Yin, J., Zhang, S.*, Liu, C., Gao, Y., Chen, M., Wang, Y., Chen, M., Fan, H., Yang, Z., Li, H., Liang, L.*, Zhou B.*, Chen X.* & Yang M.*. Substrate recognition and transport mechanism of the human proton-coupled amino-acid transporter 1 (SLC36A1). Nat Commun (2026). https://doi.org/10.1038/s41467-026-75306-z. (*corresponding author,IF=18.1)

8. Junxi Liu, Mocun Yang, Boda Zhou*. Health Equity Frameworks in Bioethical Perspective: Systemic Interventions and Innovative Justice. The American Journal of Bioethics. 2025 Jun;25(6):111-112, https://doi.org/10.1080/15265161.2025.2497976.(*corresponding author,IF=17.6)

9. Fan H, Zi X, Li T, Zhou B*, Wang C*, Liu L*. Comprehensive Risk Factor Control Attenuates Excess Cardiovascular Risk in Rheumatoid Arthritis: A Prospective Cohort Study. Eur J Prev Cardiol. 2026 Sep 5:zwag467. doi: 10.1093/eurjpc/zwag467. (*co-corresponding author,IF=10.0)

10. Ahiafor M, Zhong W, Zhou B*. Acknowledgment Is Not Enforcement: Closing Commercial AI Recruitment's Transparency Gap. Am J Bioeth. 2026 Aug;26(8):67-69. doi: 10.1080/15265161.2026.2690948.(*corresponding author,IF=17.6)

11. Rui Zhang, Xue Wang*, Xinyu Fu, Liliang Ouyang, Boda Zhou*, Jie Na*. Impact of nanoplastics on human induced pluripotent stem cell-derived endothelial cells and blood vessel organoids, Green Chemical Engineering, 2026, https://doi.org/10.1016/j.gce.2026.02.005.(*co-corresponding author,IF=11.9)

12. Min Xiao, Juncheng Zhao, Zixuan Dou, Xiangyu Chen, Sunyuntao Xu, Yu Zhang, Hongxuan Fan, Xudong Chen, Ping Zhang, Zhen Huang*, Boda Zhou*, Taotao Wei*. SIRT5 mitigates metabolic abnormality in murine models of metabolic dysfunction-associated steatotic liver disease, Life Medicine, 2026;, lnag001, https://doi.org/10.1093/lifemedi/lnag001(*co-corresponding author,IF=7.7)

13. Xiao Chen, Luqi Bai, Chong Li*, Boda Zhou*. Sleep Stage-Specific HRV Feature-1 Driven Clustering Analysis: Identifying Cardiac Autonomic Endotypes with Long-term Cardiovascular Predictive Value, European Heart Journal - Digital Health, 2026 Sep 10;7(9):ztag144. doi: 10.1093/ehjdh/ztag144. (*co-corresponding author,IF=5.3)

14. Xia Y, Huang W, Zhang Z, Li Y, Chen Y, Ren H, Meng F, Qin X, Jiang P, Jin X, Zhou B*, Chen X*. Association between compound PM2.5-cold events and population-specific mortality: a time-trend ecologic study of damage amplification in Zigong, China. Arch Public Health. 2026 May 18.84(1):128. doi: 10.1186/s13690-026-01935-x. (*co-corresponding author,IF=3.2)

15. Yan S, Zhou B*. Association of circulating ANGPTL3 level with all-cause and cardiovascular mortality. Int J Cardiol Cardiovasc Risk Prev. 2026 Sep 11;31:200709. doi: 10.1016/j.ijcrp.2026.200709. (* corresponding author,IF=3.0)

16. Cai J, Zhou B*. Mortality trends due to concomitant cardiovascular disease and cancer in the United States. The Journal of Cardiovascular Aging. 2026;6:15. DOI: 10.20517/jca.2025.69. (*corresponding author,IF=4.4)

17. Aman Liu#, Xiao Chen#, Xiaomeng Xu#, Chong Li*, Boda Zhou*. Prognostic Value of Heart Rate Variability for Neurological Outcomes in Cardiac Arrest Patients: Machine learning-based analysis of the International Cardiac Arrest Research (I-CARE) Database. Resuscitation Plus, 2026, 101322, https://doi.org/10.1016/j.resplu.2026.101322. (* co-corresponding author,IF=2.4)

18. Wang L, Wen S, Ma Z*, Zhou B*. Dual residual risk of lipid and inflammation: a prospective analysis of RCII on hypertension incidence and cardiovascular prognosis in Chinese and UK populations. BMC Cardiovasc Disord. 2026 Jul 21. doi: 10.1186/s12872-026-06322-6. (* co-corresponding author,IF=3.1)

19. Si W, Lai W, Wu L, Du S, Wu Y, Li X, Zhao W, Wu L*, Zhou B*. Association between hemoglobin A1c to HDL cholesterol ratio and hypertension in middle-aged and older Chinese adults: a cross-sectional study. BMC Cardiovasc Disord. 2026 Jun 26. doi: 10.1186/s12872-026-06174-0. (* co-corresponding author,IF=3.1)

20. Yilin Yang, Wei Li, Hanyu Chen, Xiaochen Wang, Linhong Ji, Boda Zhou*, Chong Li*. Closed-loop Respiratory Intervention Enhances Sleep Ventilation and Oxygen Saturation in Healthy Participants with Rapid High-altitude Exposure. IEEE Journal of Biomedical and Health Informatics. vol. 29, no. 5, pp. 3687-3697, May 2025, doi: 10.1109/JBHI.2024.3524867.(* co-corresponding author,IF=7.7)

21. Lexin Huang#, Zixuan Dou#, Fang Fang#, Boda Zhou#, Ping Zhang and Rui Jiang*. Prediction of mortality in intensive care unit with short-term heart rate variability: machine learning-based analysis of the MIMIC-III database. Computers in Biology and Medicine. 186 (2025) 109635(#co-first author,IF=7.0)

22. Hongxuan Fan, Zhaoyu Ren, Ping Zhang, Boda Zhou*. Increased asthma burden during and post the COVID-19 pandemic among U.S. adults. Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00123-1.(*corresponding author,IF=7.1)

23. Fan H, Huang Z, Yang Y, Li J and Zhou B*. Characteristic analysis of adverse reactions of finerenone: an in-depth analysis from WHO-VigiAccess. Front. Pharmacol. (2025) 16:1545148. doi: 10.3389/fphar.2025.1545148. (*corresponding author,IF=4.8)

24. Hongxuan Fan, Zhaoyu Ren, Ping Zhang, Boda Zhou*. Authors’ response. Ann Allergy Asthma Immunol. 135 (2025) 347−351.(*corresponding author,IF=7.1)

25. Sun J, Lin PJ, Zhai X, Wang W, Jia T, Li Z, Pan Y, Ji L, Zhou B*, Li C*. Multimodal behavioral data predict stroke patient's response to BCI treatment through explainable AI. IEEE Trans Neural Syst Rehabil Eng. 2025 Oct 24;PP. doi: 10.1109/TNSRE.2025.3625222.(*co-corresponding author,IF=6.6)

26. Fan H, Yang Y, Li J, Huang Z, Zhou B*. Change in global burden of depressive and anxiety disorders due to pandemic: Insight from GBD 2021. J Affect Disord. 2025 Jul 7;390:119817. doi: 10.1016/j.jad.2025.119817(*corresponding author,IF=5.7)

27. Hongxuan Fan, Zhaoyu Ren, Ping Zhang, Boda Zhou*. COVID-19&Depression: New and Detailed Evidence from NHANES. Journal of Infection and Public Health. 2025,102770.(*corresponding author,IF=4.8)

28. Shuang Li, Hongxuan Fan, Tianjiao Li, Shanyi zhou, Zhuolin Huang, Lei Liu, Yafen Yang, Jiahui Li, Zhaoyu Ren, Yanyan Lu, Weihao Meng, Boda Zhou*, Hongqiang Ren*. Joint analysis of atherogenic index of plasma clusters and a body shape index trajectories in incident stroke risk. Lipids in Health and Disease. 2025 Oct 6. DOI:10.1186/s12944-025-02771-8. (* co-corresponding author,IF=6.9)

29. Xia Y, Maxwell A, Li Y, Chen Y, Huang W, Meng F, Ren H, Jiang P, Chen X*, Zhou B*. Effect of cold spells and heatwaves on daily new cases of COVID-19 in the Western Pacific Region: A time series analysis. Public Health. 2025 Dec 4;250:106076. doi: 10.1016/j.puhe.2025.106076.(*co-corresponding author,IF=3.2)

30. Zhang R, Zhao L, Li S, Wang Y, She F, Zhou B*, Zhang P*. Recurrent Ventricular Arrhythmia From Acquired Long QT Syndrome Due to Alcohol-Related Electrolyte Depletion. JACC Case Rep. 2025 Nov 20:105942. doi: 10.1016/j.jaccas.2025.105942(* co-corresponding author,IF=N/A)

31. Wang Yumeng, Shou Xintian, Zhang Ping, Zhou Boda*. Farnesoid X Receptor Agonist in Patients With NAFLD: A Meta-Analysis of Metabolic Benefit and Risk. American Journal of Therapeutics (2025):10.1097/MJT.0000000000001874. (* corresponding author,IF=3.5)

32. Cai J*, Maxwell A, Zhou B*. Disease burden attributable to high temperature between 1990 and 2021 in South Asia and Southeast Asia, with projections to 2045. Tropical Medicine and Health. 2025 Oct 6. DOI: 10.1186/s41182-025-00823-4. (* co-corresponding author,IF=3.5)

33. Lai W, Chen X, Wang L, Li X, Liu M, Wu L*, Zhou B*. Nonlinear association between LDL/HDL ratio and hypertension: a cross-sectional analysis based on Chinese adults. The Journal of Cardiovascular Aging. (2025) 5:12. (* co-corresponding author,IF=4.4)

34. Lai W, Wang L, Chen X, Du S, Wu Y, Wu L, Qin H, Li X, Wu L*, Zhou B*. Association between metabolic score for insulin resistance and hypertension in middle-aged and older adults: a nationwide cross-sectional and longitudinal study. Aging Clin Exp Res. 2025 Jun 13;37(1):187. (* co-corresponding author,IF=4.7)

35. Liu J, Yang M, Zhou B*. Epigenetic and Epitranscriptomic Regulation of Cardiac Metabolism in Aging and Disease. The Journal of Cardiovascular Aging. 2025;5:15. DOI: 10.20517/jca.2025.06. ( co-corresponding author,IF=4.4)

36. Lai W, Chen X, Wang L, Wu L, Li X* and Zhou B*. Association between LDL/HDL ratio and hypertension in Chinese middle-aged and older adults: a cross-sectional and longitudinal analysis based on CHARLS LDL/HDL ration and hypertension. Front. Endocrinol. (2025) 16:1484318. ( co-corresponding author,IF=5.7)

37. Liu J, Li Y, Yi X, Wang X, Zhou B*. The Difference Between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Risk of Hypertension: A Population-Based Study in Middle-Aged and Elderly Chinese. The Journal of Cardiovascular Aging. 2025;5:16. DOI: 10.20517/jca.2024.30. (* co-corresponding author,IF=4.4)

38. Fan H, Yang Y, Lu Y, Li J, Huang Z, Ren Z, Zhou B*. Global burden of acute lymphoblastic leukemia following the COVID-19 pandemic. Ann Hematol. 2025 Oct 11. doi: 10.1007/s00277-025-06639-w(*corresponding author,IF=2.4)

39. Lerui Wang, Xiao Chen, Weicheng Lai, Junxi Liu, Boda Zhou*. Association between TG/HDL-C and hypertension in Chinese middle-aged and older adults: findings from CHARLS. BMC Cardiovasc Disord. (2025): 10.1186/s12872-025-04712-w.(*corresponding author,IF=3.1)

40. Xiao Chen, Lerui Wang, Weicheng Lai, Boda Zhou*. Relationship between Atherogenic Index of Plasma and Hypertension in Chinese Middle-Aged and Older Adults: A Cross-Sectional and Longitudinal Analysis Based on CHARLS. Aging Medicine. 2025 Apr 30;8(2):107-116.(*corresponding author,IF=2.2)

41. Chang W, Zeng Q, Zhou B*. Association of education level with mortality in United States - A cross-sectional study. Acta Psychol (Amst). 2025 Feb 1;253:104774. doi: 10.1016/j.actpsy.2025.104774(*corresponding author,IF=2.1, ESI高被引,ESI热点论文)

42. Qingping Zeng, Weihong Chang, Rui Zhang, Hongxuan Fan, Aman Liu, Ping Zhang, Fei She, Boda Zhou*. Irregular Pulse and Cardiovascular Disease From NHANES (1999–2018): A Cross‐Sectional Study. Health Science Reports, 2025; 8:e70349.(*corresponding author,IF=2.1)

43. Fan H, Yang Y, Li J, Huang Z, Zhou B*. Comprehensive analysis of sparsentan-related adverse events: latest insights from VigiAccess and FAERS. J Nephrol. 2025 Dec;38(9):2881-2891. doi: 10.1007/s40620-025-02412-4. (*corresponding author,IF=2.6)

44. Maxwell A, Wang Z, Zhou B*. "Thanks, But No Thanks" for Your Sacrifice: Who Pays When the Enhanced Come Home Broken? The Super Soldier Paradox. AJOB Neurosci. 2025 Oct-Dec;16(4):260-261. (*corresponding author,IF=N/A)

45. Liu J, Qiao Q, Yang M, Wang X, Zhou B*. Association of C-reactive protein-to-lymphocyte ratio (CLR) with liver stiffness measurement (LSM): Findings from NHANES 2017 to 2018. Medicine 2025;104:30(e43457). (* corresponding author,IF=1.4)

46. Xudong Chen, Youqi Zhang, Jian Yin, Chang Liu, Min Xie, Yixue Wang, Meiying Chen, Rui Zhang, Xinyi Yuan, De Li, Xiangmei Chen, Xin Gao, Guangyan Cai, Sensen Zhang*, Boda Zhou*, Maojun Yang*. Structural basis for the reaction cycle and transport mechanism of human Na+-sulfate cotransporter NaS1 (SLC13A1). Sci. Adv. 10, eado6778 (2024) .(* co-corresponding author,IF=13.9)

47. Junxi Liu, Boda Zhou*. The dual role of HCV protein expression in communication between host cells presents potential applications in the treatment of liver fibrosis. Annals of Hepatology. 2024,101747,https://doi.org/10.1016/j.aohep.2024.101747.(corresponding author,IF=6.2)

48. Qingping Zeng, Weihong Chang, Rui Zhang, Hongxuan Fan, Zixuan Dou, Aman Liu, Jie Yu *, Boda Zhou*. Association of cancer with heart failure, and the prognostic value of NT-proBNP in cancer patients: findings from the NHANES (1999-2018). Curr. Oncol. 2024, 31(9), 4927-4939.(*co-corresponding author,IF=2.8)

49. Luo J#, Zhou B#, Yang J, Qian H, Zhao Y, She F, Liu F and Zhang P *. Recurrent ventricular arrhythmias and heart failure induced by osimertinib- a case report. Front. Cardiovasc. Med. (2024) 11:1423647. (#co-first author,IF=2.8)

50. Zhiyu Gu#, Rui Zhang#, Weihong Chang#, Hongxuan Fan, Zixuan Dou, Peng Liu, Aman Liu, Boda Zhou*. eGFRCystatin C, difference between eGFRCystatin C and eGFRCre and Heart Failure: Insight from the NHANES 2001-2002 and Mendelian randomization analysis. International Journal of Cardiology Cardiovascular Risk and Prevention. 23 (2024) 200337. (*corresponding author,IF=4.4)

51. Xudong Chen, Mingze Zhou, Sensen Zhang, Jian Yin, Ping Zhang, Xujun Xuan, Peiyi Wang, Zhiqiang Liu*, Boda Zhou*, Maojun Yang*. Cryo-EM structures and transport mechanism of human P5B type ATPase ATP13A2. Cell Discov. 2021 Nov 2;7(1):106. doi: 10.1038/s41421-021-00334-6.(* co-corresponding author,IF=16.9)

52. Zhou B#, Xiao M#, Hu H#, Pei X, Xue Y, Miao G, Wang J, Li W, Du Y, Zhang P, Wei T. Cardioprotective Role of SIRT5 in Response to Acute Ischemia Through a Novel Liver-Cardiac Crosstalk Mechanism. Front. Cell Dev. Biol. 2021 Jul 22;9:687559. doi: 10.3389/fcell.2021.687559(# co-first author,IF=4.6)

53. Guo J#, Zhou B#, Zhu M#, Yuan Y#, Wang Q, Zhou H, Wang X, Lv T, Li S, Liu P, Yang Y, He P, Zhang P. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study. Epidemiol Infect. 2020 Oct 1;148:e241. doi: 10.1017/S0950268820002368(# co-first author,IF=4.4)

54. Niu J, Lu Y, Xu R, Fang F, Hong S, Huang L, Xue Y, Fei J, Zhang X, Zhou B*, Zhang P*, Jiang R*. The prognostic value of intraoperative HRV during anesthesia in patients presenting for non-cardiac surgery. BMC Anesthesiol. 2023 May 9;23(1):160.(*co-corresponding author,IF=2.4)

55. Zhou B#, Du Y#, Xue Y, Miao G, Wei T, Zhang P. Identification of Malonylation, Succinylation, and Glutarylation in Serum Proteins of Acute Myocardial Infarction Patients. Proteomics Clin Appl 2020 Jan;14(1):e1900103(# co-first author,IF=3.6)

56. Xue Y#, Zhou B#, Wang W, Miao G, Zhang O, Zhou J, Geng Y, Zhai Y, Ren C, Zhang P. An application of RASER technique in the treatment of chronic total occlusion accompanied with stent fracture in right coronary artery: a case report. BMC Cardiovasc Disord 2019; 19(1): 273. (# co-first author,IF=3.1)

57. Zhou BD#, Zu Lingyun#, Chen Yong, Zheng Xilong, Wang Yuhui, Pan Bing, Dong Min, Zhou Enchen, Zhao Mingming, Zhang Youyi, Zheng Lemin and Gao Wei. Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration. Lipids in Health and Disease. 2017 Jan 10; 16(1):3. (#co-first author,IF=6.9)

58. Zhou B#, Margariti A, Zeng L, Habi O, Xiao Q, Martin D, Wang G, Hu Y, Wang X, Xu Q. Splicing of histone deacetylase 7 modulates smooth muscle cell proliferation and neointima formation through nuclear β-catenin translocation. Arterioscler Thromb Vasc Biol. 2011;31(11):2676-84. (#first author, IF=8.8)

59. Zhou B#, Margariti A, Zeng L, Xu Q. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc Res. 2011;90(3):413-20. (#first author, IF=12.5)

60. Zhou BD#, Ren Chuan#, Zu Lingyun, Zheng Lemin, Guo Lijun and Gao Wei. Elevated plasma migration inhibitory factor in hypertension–hyperlipidemia patients correlates with impaired endothelial function. Medicine. 2016; 95:43(e5207).(# co-first author,IF=1.4)

61. Yu Jie#, Zhou BD#, Yu Haiyi, Han Jiangli, Cui Ming, Zhang Fuchun, Wang Guisong, Guo Lijun and Gao Wei. Association between plasma ADAMTS-7 levels and severity of disease in patients with stable obstructive coronary artery disease. Medicine. 2016; 95:48(e5523). (# co-first author,IF=1.4)

62. Zhou BD#, Li Jizhao#, Chen Shaomin, Zhou Enchen, Zheng Lemin, Zu Lingyun and Gao Wei. Time course of various cell origin circulating microparticles in ST-segment elevation myocardial infarction patients undergoing percutaneous transluminal coronary intervention. Exp Ther Med. 2016; 11: 1481-1486. (# co-first author,IF=2.7)

63. Zhou BD#, Zu Lingyun, Mi Lin, Wang Guisong, Guo Lijun and Gao Wei. An analysis of patients receiving emergency CAG without PCI and the value of GRACE score in predicting PCI possibilities in NSTE-ACS patients. J Geriatr Cardiol. 2015; 12(3):246-50. (#first author, IF=3.2)

64. Zhou BD#, Guo G, Zheng LM, Zu LY, Wei Gao. Microparticles as novel biomarkers and therapeutic targets in coronary heart disease. Chin Med J(Engl). 2015;128(2):267-72. (#first author, IF=6.1)

65. Boda Zhou#, Qizhong Li#, Yajun Xue#, Lihao Huang, Jie Zhou, Ou Zhang, Ping Zhang, Gangtie Zheng. A Novel Robotic Control System Mimics Doctor's Operation to Assist Percutaneous Coronary Intervention. Cardiovascular Innovations and Applications. Vol. 6 No. 4 (2022) 225–231.(# co-first author, IF=2.0)

66. Boda Zhou#, Yajun Xue#, Jie Zhou, Shenjie Sun, Tingting Lv, Ou Zhang, Yu Geng, Guobin Miao, Ping Zhang. Fasting Blood Glucose but not TMAO is Associated with In-Stent Restenosis in Patients with Acute Coronary Syndrome. Cardiovascular Innovations and Applications. Vol. 6 No. 3 (2022) 181–190.(# co-first author, IF=2.0)

近期授权专利

1. 基于人工智能的康复训练辅助方法、系统和终端设备(中国发明专利);专利号ZL202510048475.6;本人排名:1;批准时间:2025-09-12

2. 冠脉狭窄严重程度确定方法、装置、电子设备及存储介质(中国发明专利);专利号ZL202411876580.0;本人排名:1;批准时间:2025-03-21

3. 肝脏SIRT5蛋白在制备预防和治疗急性心肌梗死的产品中的应用(中国发明专利);专利号ZL202111597915.1;本人排名:1;批准时间:2023-08-15

4. 肝脏Sirt5蛋白在制备抑制糖异生和提高糖耐量的产品中的应用(中国发明专利);专利号ZL202210354153.0;本人排名:1;批准时间:2023-04-11

5. 肝脏SIRT5蛋白在制备减少心肌纤维化面积的产品中的应用(中国发明专利);专利号ZL202111597926.X;本人排名:1;批准时间:2023-03-10

6. 提高肝脏SIRT5蛋白活性/或表达量的物质在治疗急性心肌梗死中的应用(中国发明专利);专利号ZL202110175793.0;本人排名:1;批准时间:2021-11-04

7. 一种自消毒式听诊器(中国实用新型专利);专利号ZL202222367833.4;本人排名:1;批准时间:2023-06-27

8. 人工呼吸口罩(中国实用新型专利);专利号ZL202222510771.8;本人排名:1;批准时间:2023-06-13

9. 一种穿刺装置(中国实用新型专利);专利号ZL202222367631.X;本人排名:1;批准时间:2023-06-09

10. 一种止血压迫器(中国实用新型专利);专利号ZL202222541581.2;本人排名:1;批准时间:2023-06-20

11. 高龄照护云平台v1.0(中国计算机软件著作权);证书号12219137;本人排名:1;批准时间:2023-12-13

12. 用于血管介入手术的导管推送装置和方法(中国发明专利);专利号ZL201910363538.1;本人排名:7;批准时间:2020-12-29

13. 融合图像和力信号的介入手术器具载荷识别装置及方法(中国发明专利);专利号ZL201910369069.4;本人排名:7;批准时间:2021-2-26

14. 模拟医生手术操作的血管介入手术辅助装置遥控系统(中国发明专利);专利号ZL201910372778.8;本人排名:7;批准时间:2021-1-26

15. 一种介入手术隔离转运舱(中国发明专利);专利号ZL202111487172 .2;本人排名:6;批准时间:2022-04-08

学术荣誉及奖励

1. 国之名医-青年新锐,2026致敬医者评选组织委员会,2026年9月

2. 北京市高层次公共卫生技术人才,北京市卫生健康委员会,2023年12月

3. 2023年研究型医院评价-研究型人才,中国研究型医院学会,2023年12月

4. 首届“临床医学奖”,临床医学奖组织委员会,2023年8月

5. 第十一届“姜必宁奖-年度优良临床病例龙珠奖” ,财团法人心脏医学研究发展基金,2021年12月

6. 第三届“中青年心血管病学菁英”,中华医学会心血管病学分会青年学组,2021年6月

7. 首都医学科技创新成果转化优促计划潜力项目,北京市卫生健康委员会,2025年12月

8. BAS/BSCR Young Investigator Award, British Atherosclerosis Society, 2011年7月

9. 2022年昌平区第二十三届北京市青年学术演讲比赛二等奖,北京市昌平区科学技术协会,2022年8月

学术兼职

中华医学会心血管病分会青年学组成员,北京医学会心血管病分会青年工作组副组长,中国医师学会心血管医师分会肿瘤心脏病学组委员,中国老年医学学会全国委员,国家心血管疾病质控中心成员,中国老年保健医学研究会数智健康分会委员,中国医院协会医学人工智能专业委员会委员,国际肿瘤心脏病学会(IC-OS) Member和IC-OS Chinese Chpater Member等任职。获国之名医-青年新锐,首届临床医学奖,第十一届姜必宁奖,第三届中青年心血管病学菁英,中国研究型医院学会-研究型人才,BAS/BSCR Young Investigator Award等荣誉。担任《Public Health》、《The Journal of Cardiovascular Aging》《Aging Medicine》、《Reviews in Cardiovascular Medicine》、《American Journal of Health Research》、《Annals of Cardiovascular Diseases》等杂志编委,以及国家自然科学基金生物医学科学处、国家科技创新2030重大项目、首都卫生发展科研专项基金、北京市自然科学基金评议人。

TOP